Objective: Chest trauma-induced brain injury (CTBI) is caused by the formation of inflammatory cytokines in the lungs and blood. Cannabidiol (CBD), a non-psychoactive agent, has antioxidant, anti-inflammatory, and antiapoptotic properties. In this study, we aimed to investigate the protective effects of CBD on CTBI.
Material and Method: Forty male Wistar Albino rats were divided into four groups: control, CTBI (200 g weight drop on the anterior chest wall from a height of 1 meter), CTBI+CBD (5 mg/kg, single dose intraperitoneally), and CBD. After 48 hours, rats were sacrificed under anesthesia, and brain tissues were placed in a 10% formaldehyde solution for histopathological and immunohistochemical examination.
Results: In the CTBI group, hemorrhagic areas, tumor necrosis factor-alpha, caspase-3, and malondialdehyde expressions increased in histological and immunohistochemical examinations compared to the control group. CBD treatment reduced hemorrhagic areas and reversed immune expressions.
Conclusion: Inflammation, apoptosis, and oxidative stress in brain tissue may develop in CTBI. These damages can be corrected with CBD treatment.
The study was carried out at Süleyman Demirel University Experimental Animal Production and Experimental Research Laboratory. Ethical approval was obtained from the National Institutes of Health and approved by the Local Ethics Committee for Animal Experiments of Suleyman Demirel University (Approval No. 2023-01/116).
This study was supported by the project coded "TSG-2023-9010," funded by the Scientific Research Coordination Unit of Süleyman Demirel University.
TSG-2023-9010
None.
TSG-2023-9010
Primary Language | English |
---|---|
Subjects | Brain and Nerve Surgery (Neurosurgery), Thoracic Surgery, Medical Pharmacology, Chest Diseases |
Journal Section | Research Articles |
Authors | |
Project Number | TSG-2023-9010 |
Publication Date | December 26, 2024 |
Submission Date | July 11, 2024 |
Acceptance Date | November 25, 2024 |
Published in Issue | Year 2024 Volume: 31 Issue: 4 |
Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi/Medical Journal of Süleyman Demirel University is licensed under Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International.